[1]
Del Rosso, J., Kircik, L. , Stein Gold, L., Baldwin, H. , Weiss, J. , Pariser, D., Callender, V. , Lain, E. , Gold, M., Beer, K. , Draelos, Z., Sadick, N., Pillai, ; R., Bhatt, V. and Tanghetti, E. 2022. Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: Phase 2 Study of the First Triple-Combination Drug. SKIN The Journal of Cutaneous Medicine. 6, 2 (Mar. 2022), s17. DOI:https://doi.org/10.25251/skin.6.supp.17.